Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $797.8700 (0.04%) ($797.8700 - $797.8700) on Mon. Nov. 27, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.03% (three month average) | RSI | 19 | Latest Price | $797.8700(0.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) SDY(52%) SPLV(45%) XLU(43%) XLV(43%) | Factors Impacting REGN price | REGN will decline at least -0.515% in a week (0% probabilities). USO(-33%) ONLN(-30%) VXX(-28%) UNG(-25%) XLE(-22%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.515% (StdDev 1.03%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $801.96 | 5 Day Moving Average | $798.97(-0.14%) | 10 Day Moving Average | $797.52(0.04%) | 20 Day Moving Average | $801.96(-0.51%) | To recent high | -5.6% | To recent low | 3% | Market Cap | $84.597b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |